Nikkiso Of Japan Partners With Baxter To Market Dialysis Systems
This article was originally published in PharmAsia News
Executive Summary
Japanese dialysis systems manufacturer Nikkiso has contracted with Baxter International to sell its products in northern Europe, China and South Korea. Nikkiso produces about 10,000 of the systems each year and expects Baxter's global network to increase sales by another 2,000 a year. Baxter marketing efforts were expected to begin as early as by the end of May. (Click here for more - a subscription may be required
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.